• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.近四倍体/四倍体急性髓系白血病的临床病理分析
J Clin Pathol. 2015 Mar;68(3):236-40. doi: 10.1136/jclinpath-2014-202697. Epub 2015 Jan 6.
2
Tetraploidy/near-tetraploidy acute myeloid leukemia.四倍体/近四倍体急性髓系白血病
Leuk Res. 2017 Feb;53:20-27. doi: 10.1016/j.leukres.2016.11.016. Epub 2016 Dec 2.
3
Near-tetraploidy/tetraploidy acute myeloid leukemia with clinical, pathologic and molecular characteristics.具有临床、病理和分子特征的近四倍体/四倍体急性髓系白血病。
Leuk Lymphoma. 2024 Dec;65(12):1820-1829. doi: 10.1080/10428194.2024.2382923. Epub 2024 Jul 25.
4
[Preliminary analysis of genetics and clinical features of patients with acute myeloid leukemia and near-tetraploid/tetraploidy karyotype].急性髓系白血病伴近四倍体/四倍体核型患者的遗传学及临床特征初步分析
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018 Oct 10;35(5):733-736. doi: 10.3760/cma.j.issn.1003-9406.2018.05.026.
5
The prognostic implications of tetraploidy/near-Tetraploidy in acute myeloid leukemia: a case series and systematic review of the literature.四倍体/近四倍体在急性髓系白血病中的预后意义:病例系列和文献系统评价。
Leuk Lymphoma. 2021 Jan;62(1):203-210. doi: 10.1080/10428194.2020.1817435. Epub 2020 Sep 29.
6
Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.西澳大利亚州 1991-2005 年急性髓系白血病:对 898 例患者进行回顾性基于人群的研究,涉及流行病学、细胞遗传学、治疗和结果。
Intern Med J. 2013 Aug;43(8):903-11. doi: 10.1111/imj.12169.
7
Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.初诊时急性髓系白血病的预后参数
Med Arch. 2017 Feb;71(1):20-24. doi: 10.5455/medarh.2017.71.20-24. Epub 2017 Feb 5.
8
[Successful treatment with reduced-intensity cord blood transplantation for acute myeloid leukemia with complete tetraploidy (92, XXXX)].[采用低强度脐血移植成功治疗完全四倍体(92, XXXX)急性髓系白血病]
Rinsho Ketsueki. 2011 Mar;52(3):124-8.
9
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.BAALC 过表达在急性髓系白血病患者的所有细胞遗传学风险组中保留其负预后作用。
Am J Hematol. 2013 Oct;88(10):848-52. doi: 10.1002/ajh.23516. Epub 2013 Jul 23.
10
Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.伴有t(v;5q33)的急性髓系白血病与总体生存率低相关,且通常缺乏骨髓增生异常特征。
Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S85-90. doi: 10.1016/j.clml.2015.02.007.

引用本文的文献

1
Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid Leukemia.新型复发性细胞遗传学异常可预测四倍体/近四倍体骨髓增生异常综合征和急性髓系白血病的总生存期。
Cancers (Basel). 2025 Apr 10;17(8):1277. doi: 10.3390/cancers17081277.
2
Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging Treatments.癌症中的多倍体:因果机制、癌症特异性后果和新兴治疗方法。
Mol Cancer Ther. 2024 May 2;23(5):638-647. doi: 10.1158/1535-7163.MCT-23-0578.
3
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia.急性髓系白血病免疫表型参数与分子改变之间的关联
Biomedicines. 2023 Apr 5;11(4):1098. doi: 10.3390/biomedicines11041098.
4
Mixed phenotype acute leukemia, B/myeloid, NOS with near-tetraploidy: a case report.混合表型急性白血病,B/髓系,NOS伴近四倍体:一例报告
Int J Clin Exp Pathol. 2017 Nov 1;10(11):11206-11210. eCollection 2017.
5
Acute Myeloid Leukemia with Philadelphia Chromosome, Near-tetraploidy, and 5q Deletion.伴有费城染色体、近四倍体和5号染色体长臂缺失的急性髓系白血病
Cureus. 2019 Sep 9;11(9):e5606. doi: 10.7759/cureus.5606.
6
Blast vacuolization in AML patients indicates adverse-risk AML and is associated with impaired survival after intensive induction chemotherapy.急性髓系白血病患者的 blast vacuolization 提示为不良风险的 AML,与强化诱导化疗后生存受损相关。
PLoS One. 2019 Sep 30;14(9):e0223013. doi: 10.1371/journal.pone.0223013. eCollection 2019.
7
Telomere Shortening in Hematological Malignancies with Tetraploidization-A Mechanism for Chromosomal Instability?四倍体化血液系统恶性肿瘤中的端粒缩短——染色体不稳定的一种机制?
Cancers (Basel). 2017 Nov 30;9(12):165. doi: 10.3390/cancers9120165.
8
Acute myeloid leukemia with e1a2 BCR-ABL1 fusion gene: two cases with peculiar molecular and clinical presentations.伴有e1a2 BCR-ABL1融合基因的急性髓系白血病:两例具有特殊分子和临床表现的病例
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):379-384. doi: 10.1016/j.bjhh.2017.07.001. Epub 2017 Aug 3.
9
Tetraploidy acute myeloid leukaemia after chromosome 16 inversion.16号染色体倒位后的四倍体急性髓系白血病
BMJ Case Rep. 2017 Mar 22;2017:bcr2017219274. doi: 10.1136/bcr-2017-219274.

本文引用的文献

1
Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasia.一位 67 岁近四倍体急性髓细胞白血病 m0 患者,无红系和巨核细胞发育异常,生存时间异常延长。
Acta Haematol. 2011;126(3):129-34. doi: 10.1159/000328199. Epub 2011 Jun 24.
2
Enlarged and prominent nucleus may be indicative of tetraploidy: a laboratory study of a rare near-tetraploidy in a child patient with acute myelogenous leukemia AML-M4.细胞核增大且突出可能提示四倍体:一名急性髓系白血病AML-M4儿童患者罕见近四倍体的实验室研究。
J Pediatr Hematol Oncol. 2010 Jan;32(1):19-21. doi: 10.1097/MPH.0b013e3181b794b2.
3
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.细胞遗传学和年龄是60岁以上接受强化治疗的急性髓系白血病患者预后的主要决定因素:来自AMLSG试验AML HD98 - B的结果
Blood. 2006 Nov 15;108(10):3280-8. doi: 10.1182/blood-2006-04-014324. Epub 2006 Jul 13.
4
Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases.近四倍体急性髓系白血病:一项对25例病例的欧洲白血病免疫学分型(EGIL)回顾性研究。
Leukemia. 2006 Apr;20(4):725-8. doi: 10.1038/sj.leu.2404110.
5
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.急性髓细胞白血病和骨髓增生异常综合征中的大量超二倍体和四倍体。
Cancer Genet Cytogenet. 2004 Jan 1;148(1):29-34. doi: 10.1016/s0165-4608(03)00214-0.
6
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.急性髓系白血病治疗试验的诊断、反应标准标准化、治疗结果及报告标准国际工作组修订建议
J Clin Oncol. 2003 Dec 15;21(24):4642-9. doi: 10.1200/JCO.2003.04.036.
7
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.老年急性髓系白血病(AML)患者中细胞遗传学分层分类的预测价值:对纳入英国医学研究委员会AML11试验的1065例患者的分析
Blood. 2001 Sep 1;98(5):1312-20. doi: 10.1182/blood.v98.5.1312.
8
Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors.三例起源于多能髓系祖细胞的近四倍体急性髓系白血病。
Leuk Res. 1998 Jul;22(7):581-8. doi: 10.1016/s0145-2126(97)00177-x.
9
Two new cases of near-tetraploidy in adult acute myeloid leukemia.成人急性髓系白血病中两例新的近四倍体病例。
Cancer Genet Cytogenet. 1998 Apr 15;102(2):131-4. doi: 10.1016/s0165-4608(97)00315-4.
10
Near tetraploidy in three cases of acute myeloid leukemia associated with mediastinal granulocytic sarcoma.三例急性髓系白血病合并纵隔粒细胞肉瘤患者出现近四倍体。
Cancer Genet Cytogenet. 1998 Apr 1;102(1):50-3. doi: 10.1016/s0165-4608(97)00294-x.

近四倍体/四倍体急性髓系白血病的临床病理分析

Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia.

作者信息

Pang Changlee S, Pettenati Mark J, Pardee Timothy S

机构信息

Department of Pathology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, North Carolina, USA.

Department of Genetics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, North Carolina, USA.

出版信息

J Clin Pathol. 2015 Mar;68(3):236-40. doi: 10.1136/jclinpath-2014-202697. Epub 2015 Jan 6.

DOI:10.1136/jclinpath-2014-202697
PMID:25563333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4886850/
Abstract

AIMS

Near-tetraploidy/tetraploidy (NT/T) is a rare cytogenetic alteration in acute myeloid leukaemia (AML). NT/T-AML is categorised as complex cytogenetics and therefore, presumed to have an unfavourable prognosis. Our aim is to further characterise the clinical, morphological, cytogenetic and prognostic features of NT/T-AML.

METHODS

We searched our cytogenetic laboratory database from 1991 to 2012 to reveal 13 cases of NT/T-AML. Each case was evaluated with regard to its demographics, morphology, immunophenotype and prognosis. Specific morphological features included blast size, irregularity of nuclear contours, cytoplasmic vacuoles, and presence and lineage of dysplasia.

RESULTS

Eleven men and two women had a median age of 68 years. Blasts were predominately large (11/13). Eight of 13 patients had AML with myelodysplasia-related changes. Sixty-nine per cent of patients achieved complete remission (CR). Median overall survival (OS) was 8.6 months. CR rate and median OS in cases with ≥ 5 cytogenetic abnormalities were 71% and 6 months, compared with 67% and 18.1 months in cases with <5 abnormalities.

CONCLUSIONS

NT/T-AML occurs in older males, exhibits large blast size and is associated with myelodysplasia. Unlike previously reported data, our study reveals an overall better prognosis in this older population with NT/T-AML than was expected for a complex karyotype AML. Cytogenetic complexity independent of ploidy status did not greatly affect the high CR rates, but did appear to be a better estimation of prognostic risk in terms of median OS.

摘要

目的

近四倍体/四倍体(NT/T)是急性髓系白血病(AML)中一种罕见的细胞遗传学改变。NT/T-AML被归类为复杂细胞遗传学,因此,推测其预后不良。我们的目的是进一步描述NT/T-AML的临床、形态学、细胞遗传学和预后特征。

方法

我们检索了1991年至2012年我们细胞遗传学实验室数据库,以找出13例NT/T-AML病例。对每个病例的人口统计学、形态学、免疫表型和预后进行评估。具体形态学特征包括原始细胞大小、核轮廓不规则、细胞质空泡以及发育异常的存在和谱系。

结果

11名男性和2名女性,中位年龄为68岁。原始细胞主要为大细胞(13例中的11例)。13例患者中有8例患有与骨髓发育异常相关改变的AML。69%的患者达到完全缓解(CR)。中位总生存期(OS)为8.6个月。细胞遗传学异常≥5例的患者CR率和中位OS分别为71%和6个月,而细胞遗传学异常<5例的患者分别为67%和18.1个月。

结论

NT/T-AML发生于老年男性,表现为原始细胞大,且与骨髓发育异常相关。与先前报道的数据不同,我们的研究显示,在这个患有NT/T-AML的老年人群中,总体预后比复杂核型AML预期的要好。独立于倍体状态的细胞遗传学复杂性并未对高CR率产生很大影响,但就中位OS而言,似乎是预后风险的更好估计。